Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Oliver Adunka

Otolaryngology Columbus, OH Medical Doctor

NPI 1316975444 CMS profile 240954

915 Olentangy River Rd, Columbus, OH 43212

Open in the dashboard

General payments

$337,879

94 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$663,060 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Oliver Adunka of Columbus, OH is reported in the CMS Open Payments database as having received $337,879 across 94 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $663,060 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Otolaryngology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $58,242 6
2024 General $23,124 22
2023 General $55,519 20
2022 General $62,522 25
2021 General $423 4
2020 General $138 6
2019 General $137,912 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Oliver Adunka
  • Otolaryngology median
  • Middle half of Otolaryngology
  • National median

In program year 2025, general payments to Oliver Adunka were reported at $58,242. Among 6,588 Otolaryngology profiles paid that year, the median was $317 and the middle half received between $125 and $815.

Show as a table
Year Oliver Adunka Otolaryngology median Middle half National median
2019 $137,912 $194 $82–$512 $163
2020 $138 $118 $42–$280 $114
2021 $423 $167 $63–$444 $132
2022 $62,522 $216 $84–$545 $149
2023 $55,519 $235 $93–$588 $160
2024 $23,124 $280 $111–$699 $164
2025 $58,242 $317 $125–$815 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Advanced Bionics, LLC $311,575 29 payments
  2. MED-EL Corporation $23,941 43 payments
  3. Cochlear Americas $2,011 18 payments
  4. iotaMotion, Inc $183 2 payments
  5. Medtronic, Inc. $169 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $171,533 4 payments
  2. Consulting Fee $131,180 4 payments
  3. Travel and Lodging $22,121 19 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,500 1 payment
  5. Food and Beverage $4,408 63 payments
  6. Education $1,137 3 payments
Products named General payments · program years 2019–2025
  1. HIRES ULTRA CI HIFOCUS MS ELECTRODE $173,589 13 payments
  2. HiResolution Bionic Ear System $137,986 16 payments
  3. Mi1250 SYNCHRONY 2 FLEXsoft $23,428 38 payments
  4. BCI 602 Kit $22,949 30 payments
  5. ADHEAR Professional Kit $21,623 15 payments
  6. BAHA $1,958 17 payments
  7. Cochlear Implantable hearing solution $1,328 8 payments
  8. Cochlear Implantable hearing solution $1,328 8 payments
  9. Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode $683 10 payments
  10. OSIA OSI300 IMPLANT $630 9 payments
  11. Other $961 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

25

Median for Otolaryngology: 297

Drug cost

$85

Median for Otolaryngology: $6,314

Branded share of claims

52%

Median for Otolaryngology: 10.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid Brand 13 $51
Prednisone Generic 12 $34

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,296 Part D prescribers listed as Otolaryngology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$84,124

Medicare's payments for the services billed

Medicare patients

191

Average age 71

Services billed

342

99 women, 92 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Arthritis 45%
Ischemic heart disease 31%
Diabetes 30%
Depression 21%
Osteoporosis 20%
Chronic kidney disease 19%
Cancer 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

94 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Otolaryngology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record